Renal Medullary Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Medullary Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Compassionate Use of Ubamatamab
The document notes compassionate-use access to Ubamatamab for renal medullary carcinoma and epithelioid sarcoma, sponsored by Regeneron, wit…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Phase II Trial of Nivolumab Plus Ipilimumab in Patients With Renal Medullary Carcinoma [Phase 2]
A Phase II trial of nivolumab plus ipilimumab in patients with Renal Medullary Carcinoma has been terminated, with the study status updated.
-
CLINICAL_TRIALS trial_result · 2025-11-04Clinical Trial Update: A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study [Phase 1, Phase 2]
This document reports the completion of a long-term safety study of tazemetostat in adults who previously received the drug in earlier trial…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma [Phase 2]
Phase 2 study of tazemetostat in adult participants with soft tissue sarcoma, including rhabdoid tumors, has completed and results were post…
-
CLINICAL_TRIALS trial_result · 2024-08-26Clinical Trial Update: Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels [Phase 1]
Phase 1 trial assessing the pharmacokinetic interactions of itraconazole and rifampin with tazemetostat; results published for patients with…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.